MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 214 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q1 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $241 | -18.3% | 24,212 | +2.0% | 0.00% | – |
| Q2 2023 | $295 | -45.7% | 23,726 | -38.7% | 0.00% | – |
| Q1 2023 | $543 | +570.4% | 38,736 | +578.9% | 0.00% | – |
| Q4 2022 | $81 | -100.0% | 5,706 | -46.2% | 0.00% | – |
| Q3 2022 | $270,000 | +0.7% | 10,597 | +12.6% | 0.00% | – |
| Q2 2022 | $268,000 | +55.8% | 9,410 | +92.4% | 0.00% | – |
| Q1 2022 | $172,000 | – | 4,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |